---
title: "Moderna Tumbles 10% During Regular Trading on Vaccine Adoption Concerns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292337141.md"
description: "Moderna (MRNA) fell 10% to $68.66 as respiratory vaccine adoption lagged expectations and clinical trials faced delays."
datetime: "2026-07-10T15:11:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292337141.md)
  - [en](https://longbridge.com/en/news/292337141.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292337141.md)
---

# Moderna Tumbles 10% During Regular Trading on Vaccine Adoption Concerns

Moderna(MRNA.US) 盘中跌超**10%**，现报**68.66**美元。

下跌源于投资者对公司后疫情时代转型的担忧，呼吸道疫苗采用率低于预期，临床试验出现延迟。此外，QRG Capital 披露新 Q1 仓位，持有约**1.37 万**股，价值约**69.4 万**美元。

### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)

## Related News & Research

- [Moderna (MRNA) Stock Looks Above Fair Value After Cancer Trial News](https://longbridge.com/en/news/293731075.md)
- [Moderna (MRNA) Adds Finance Veteran To Its Board, Is The Stock Fully Valued?](https://longbridge.com/en/news/293478959.md)
- [Assessing Moderna (MRNA) Valuation After Flu Vaccine Data And Hantavirus Program Interest](https://longbridge.com/en/news/286642428.md)
- [Moderna (MRNA) Is Up 5.4% After Fast Track Win For Melanoma mRNA Therapy Combo – Has The Bull Case Changed?](https://longbridge.com/en/news/283242733.md)
- [How Investors Are Reacting To Moderna (MRNA) CEPI Funding For Its Ebola Vaccine Program](https://longbridge.com/en/news/288310379.md)